FDA inspection
Rising Pharma Holding, Inc.: FDA inspection ending Nov 3, 2023
FDA inspection 1223241 · No Action Indicated (NAI) · East Brunswick, NJ
Key facts
| Inspection ID | 1223241 |
|---|---|
| Firm | Rising Pharma Holding, Inc. |
| FEI number | 3015784623 |
| Address | 2 Tower Center Blvd Ste 1401 |
| City | East Brunswick |
| State | NJ |
| ZIP | 08816 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Nov 3, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data